ES523244A0 - "procedimiento para la obtencion de una composicion a base de 1,4-dihidropiridina de accion anti-arteriosclerotica". - Google Patents

"procedimiento para la obtencion de una composicion a base de 1,4-dihidropiridina de accion anti-arteriosclerotica".

Info

Publication number
ES523244A0
ES523244A0 ES523244A ES523244A ES523244A0 ES 523244 A0 ES523244 A0 ES 523244A0 ES 523244 A ES523244 A ES 523244A ES 523244 A ES523244 A ES 523244A ES 523244 A0 ES523244 A0 ES 523244A0
Authority
ES
Spain
Prior art keywords
procedure
based composition
arteriosclerotic action
dihydropyridine
dihydropyridine based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES523244A
Other languages
English (en)
Other versions
ES8403456A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8403456A1 publication Critical patent/ES8403456A1/es
Publication of ES523244A0 publication Critical patent/ES523244A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES523244A 1982-06-15 1983-06-14 "procedimiento para la obtencion de una composicion a base de 1,4-dihidropiridina de accion anti-arteriosclerotica". Granted ES523244A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823222367 DE3222367A1 (de) 1982-06-15 1982-06-15 Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung

Publications (2)

Publication Number Publication Date
ES8403456A1 ES8403456A1 (es) 1984-03-16
ES523244A0 true ES523244A0 (es) 1984-03-16

Family

ID=6166052

Family Applications (1)

Application Number Title Priority Date Filing Date
ES523244A Granted ES523244A0 (es) 1982-06-15 1983-06-14 "procedimiento para la obtencion de una composicion a base de 1,4-dihidropiridina de accion anti-arteriosclerotica".

Country Status (9)

Country Link
JP (1) JPS595114A (es)
BE (1) BE897035A (es)
CA (1) CA1228549A (es)
DE (1) DE3222367A1 (es)
ES (1) ES523244A0 (es)
FR (1) FR2528425B1 (es)
IL (1) IL68970A0 (es)
IT (1) IT1175920B (es)
ZA (1) ZA834344B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
GB2180532B (en) * 1985-09-17 1989-08-23 Inst Organicheskogo Sinteza Ak Alkoxy-and phenoxy-alkyl-esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
DE4328884A1 (de) * 1993-08-27 1995-03-02 Bayer Ag Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
AU2002361992A1 (en) * 2001-12-20 2003-07-09 Bayer Aktiengesellschaft 1,4-dihydro-1,4-diphenylpyridine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2335466A1 (de) * 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE3222367A1 (de) 1983-12-15
IT8321465A0 (it) 1983-06-03
FR2528425A1 (fr) 1983-12-16
JPS595114A (ja) 1984-01-12
CA1228549A (en) 1987-10-27
IT1175920B (it) 1987-08-12
BE897035A (fr) 1983-12-13
JPH0553774B2 (es) 1993-08-10
DE3222367C2 (es) 1992-02-13
ZA834344B (en) 1984-03-28
ES8403456A1 (es) 1984-03-16
FR2528425B1 (fr) 1987-02-06
IL68970A0 (en) 1983-10-31

Similar Documents

Publication Publication Date Title
DE69019022T2 (de) Ölige Pasten-Zusammensetzung.
FI831664L (fi) 1,3-dioxan-5-ylalkenoylsyror
DK587183A (da) 1,4-benzodiazepin-derivater
ES545429A0 (es) Procedimiento para la obtencion de una composicion de blanqueo a base de hipoclorite.
DE3382204D1 (de) 1,4-dihydropyridin-derivate.
ES520973A0 (es) Una composicion fundente.
ATE61055T1 (de) 1,4-dihydropyridine.
FI830135L (fi) Goedselmedel, ur vilka naeringsaemnenas frigivning inleds reglerat
DE3377128D1 (de) 1,3-dioxanes
ES523244A0 (es) "procedimiento para la obtencion de una composicion a base de 1,4-dihidropiridina de accion anti-arteriosclerotica".
IT7926502A0 (it) Composto a base di2,6-diammino-nebularina.
ES523243A0 (es) "procedimiento para preparar derivados de 1,4-dihidropiridina".
ES516357A0 (es) "procedimiento para preparar 1-(3-(6-fluor-1,2-benzisoxazol-3-il)propil)-4-fenil-4-hidroxipiperidinas".
ES554062A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas
MX158031A (es) Procedimiento para preparar una composicion quimiluminiscente a base de n,n'bis(trifluorometilsulfonil)oxamidas
DE69009823T2 (de) Zusammensetzungen, die 2-Thiocyanomethylthiobenzothiazol enthalten.
DE3371781D1 (de) 1,4-methano-2-benzazepine derivatives
DE3365097D1 (de) 6,7-dihydro-7,7-disubstituted-khellins
IT8349567A0 (it) 2,2,2-trialogeno-1-(trialogenometiletiliden-bis-benzen-tioli
ES540807A0 (es) Procedimiento para la obtencion de una composicion retardada a base de bromocriptina.
ES549334A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas
IT1189320B (it) 1-fenil-1,2,3-triazoli impiegabili come disappetenti
ES510320A0 (es) "procedimiento de obtencion de n,n,-diacetil cisteina".
ATE61579T1 (de) 1,4-dihydropyridin-derivate.
ES525842A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas